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ABSTRACT
Objective: Psychotherapy research may suffer from
factors such as a researcher’s own therapy allegiance.
The aim of this study was to evaluate if researcher
allegiance (RA) was reported in meta-analyses and
randomised controlled trials (RCTs) of
psychotherapeutic treatments.
Design: Systematic approach using meta-analyses of
different types of psychotherapies.
Data sources: Medline, PsycINFO and Cochrane
Database of Systematic Reviews.
Methods: We evaluated meta-analyses of RCTs
regarding various types of psychotherapies. Meta-
analyses were eligible if they included at least one RCT
with RA and they were published in journals in Medline,
PsycINFO and Cochrane Database of Systematic Reviews
with an impact factor larger than 5.
Results: We identified 146 eligible meta-analyses that
synthesised data from a total of 1198 unique RCTs.
Only 25 of the meta-analyses (17.2%) reported
allegiance and only 6 (4.1%) used a proper method to
control its effect. Of the 1198 eligible primary RCTs,
793 (66.3%) were allegiant. Authors in 25 of these 793
RCTs (3.2%) reported their allegiance while only one
study (0.2%) controlled for its effect.
Conclusions: The vast majority among a group of
published meta-analyses and RCTs of psychotherapeutic
treatments seldom reported and evaluated the allegiance
effect. The results of the present study highlight a major
lack of this information in meta-analyses and their
included studies, though meta-analyses perform slightly
better than RCTs. Stringent guidelines should be
adopted by journals in order to improve reporting and
attenuate possible effects of RA in future research.
INTRODUCTION
The researcher allegiance (RA) effect is of
special concern in studies that are designed
to evaluate the treatment effectiveness of dif-
ferent forms of psychotherapy,1–8 as the inves-
tigator may portray allegiances in particular
therapies which are correlated with the
pattern of the results.9 10 RA has been
deﬁned as a researcher’s ‘belief in the super-
iority of a treatment and in the superior valid-
ity of the theory of change that is associated
with the treatment’ (p55).3 Psychotherapy
research was probably one of the very ﬁrst
ﬁelds that conceptualised potential allegiance
effects for clinical interventions.11 Luborsky
et al12 13 have shown that RA accounted for
two-thirds of the variance in treatment effect
in favour of the preferred treatment. Similar
potential personal expectations and ﬁnancial
relationships favouring positive results have
also been found to affect biomedical
research.14 15
The contamination of RA in the psycho-
therapy era is a long-standing debate.
Meta-analyses have found larger effect esti-
mates in psychotherapy studies when RA is
observed.16–18 These effects are attenuated
when appropriate statistical methods for con-
trolling for RA are performed.1 4 6 12 13 16–22
The aforementioned ﬁndings led some
researchers to support the existence of alle-
giance bias,1 12 13 19 21 23 which overestimates
the effect and threatens the validity of the
clinical trials.1 21 23 On the other hand, other
Strengths and limitations of this study
▪ Researcher allegiance is widely discussed as a
potential factor that influences a researcher’s
actions and the reporting of results in the con-
ducted studies. However, information on the
reporting of allegiance in published meta-analyses
has not yet been systematically estimated.
▪ This is the first research article that systematic-
ally evaluates the reporting of researcher alle-
giance in a large scale dataset of 146
meta-analyses and 1198 unique randomised
controlled studies of psychotherapy for a broad
range of outcomes.
▪ The criterion of selecting eligible meta-analyses
based on a journal’s impact factor must be con-
sidered with caution.
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researchers argue that RA should be viewed as a reﬂec-
tion of the true differences among psychotherapies
boosted by the clinical and research expertise,24 25 and
cannot be considered as existence of bias per se.3
Statistical correction for the presence of allegiance is
therefore pointless and may introduce bias.25 This is
supported by additional meta-analyses which have
shown that RA did not divert the relative treatment
effect, concluding that RA was not an important source
of bias.26–28
Allegiance is an essential topic and—bias or not—
related researchers seem at least to agree that it should be
taken into account effectively. Several sources of allegiance
have been provided in order to clarify how allegiance
could affect the outcome in randomised controlled trials
(RCTs). These could include poor training of therapists,
the enthusiasm of the researcher for a particular treat-
ment and the ‘ﬁle drawer phenomenon’.3 Furthermore,
the nature of psychotherapy, in contradiction to pharma-
cotherapy, is very difﬁcult to study. Methodological weak-
ness such as wait-list control groups, single group designs,
small samples and subjective measurement of clinical
improvement may allow RA to interfere.29 Along with the
fact that, in the ﬁeld of psychotherapy, double-blind
studies cannot be applied, RA may inﬂuence a research-
er’s actions and its reporting in the conducted studies
which could be considered as a potential non-ﬁnancial
conﬂict of interest.30 However, this type of allegiance bias
is not easily detectable. Recently, a new mechanism has
suggested that the RA effect may occur partly whenever
researchers select biased therapists in study designs.31 It is
also a fact that RA could affect the outcome whenever
researchers select study therapists who share the RA
according to the true efﬁcacy hypothesis.19 Similar
mechanisms could occur regarding meta-analyses and
studies selection.29 Meta-analysis reﬂects the potential
methodological deﬁcits of the primary studies due to the
presence of RA. Thus, meta-analyses could display the
same methodological deﬁcits as the primary studies in
meta-analysis design, data analysis and interpretation of
results because of RA by the authors of the meta-analysis.
The developers of some speciﬁc psychological treatments
may show more interest in the evidence-based practice of
their own therapies than in others.30 The RA of authors
of a meta-analysis is found to correlate with the outcomes
of the meta-analysis.6 23
Although the authors of meta-analyses are required to
evaluate all potential biases by the broadly used guide-
lines,32 33 there are no speciﬁc guidelines in psychother-
apy meta-analyses about clearly addressing the problem
of RA. RA is an important factor in showing the beneﬁts
of a preferred treatment and therefore attention should
be given when interpreting the results of RCTs (eg, ther-
apist allegiance). Moreover, without reporting RA in
meta-analyses, the evaluation of the evidence derived
may be limited. It is reasonable to assume that neglect-
ing to report RA could be considered as a methodo-
logical issue.
In this study we aim to investigate systematically the
extent of reporting RA in meta-analyses of RCTs of psy-
chotherapy treatments as well as in the primary RCTs
included in these meta-analyses. We searched journals
with a relative high impact factor (IF) and enhanced
our sample size by including studies from the Cochrane
Database of Systematic Reviews (CDSR). Our hypothesis
is that RA is not reported in both meta-analyses and
their included RCTs. We also hypothesised that the alle-
giance effect is assessed in only a few meta-analyses and
RCTs.
METHODS
Selection of meta-analyses
We conducted a comprehensive literature search of
meta-analyses in the psychotherapy ﬁeld published from
January 1977 to December 2012. We searched PubMed,
PsycINFO and the CDSR using the following search
algorithm: (meta-analysis OR systematic review) AND (psycho-
therapy OR psychoanalysis OR psychological interventions).
Both Medical Subject Headings (MeSH) terms and text
words were used. From CDSR we selected the most
recent version of previously published psychotherapy
reviews. The last update was performed in December
2012. To increase the yield of our electronic search,
reference lists of all eligible studies and relevant review
articles were examined until a comprehensive list was
obtained. This systematic review was performed in accord-
ance with the Preferred Reporting Items for Systematic
Review and Meta-analyses (PRISMA) statement (on line
supplement 1; PRISMA 2009 Checklist).
Eligibility criteria
We considered published meta-analyses of RCTs of psy-
chotherapeutic treatments in journals with a 2012 IF
of ≥5 based on Journal Citation Report ( JCR, 2012).
We selected high impact journals of published meta-
analyses to reﬂect current reporting practices because
they have higher reporting standards.32 33 The selec-
tion criterion of IF has previously been applied to
studies of reporting.15 Meta-analyses of RCTs with at
least one study with RA were eligible. We based our
decision in order to have a strict criterion since the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement requires authors of
meta-analyses to report both potential source of bias
and conﬂicts of interest (COIs) of a meta-analysis,32
but does not address the reporting of such biases from
included RCTs.
A study was deﬁned as showing RA when one or
more of the co-authors had (1) developed the inter-
vention; (2) developed both the therapy and trained
the therapists; (3) developed both the intervention
and supervised the therapists; (4) supervised and/or
trained the therapists alone; or (5) advocated the
therapy.2 The highest level of allegiance was coded as
5 if the psychotherapy treatment was developed by the
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author(s) and if they supervised or trained the thera-
pists; 4 if the treatment was developed by the authors
but they did not train or supervise the therapists; 3 if
the treatment was advocated by one of the authors
and they also supervised/trained the therapists; 2 if
the treatment was advocated by the authors but they
did not train or supervise therapists or in cases where
the author showed no advocacy for the psychotherapy
but provided better trained or more experienced
therapists for one treatment over another; 1 if the
treatment was more fully explained in the introduction
and/or methods section than the alternative; and 0 if
there was no apparent advocacy of one treatment over
another. When sufﬁcient information on RA was not
given in the full text, we additionally checked the
References section in order to identify if a reference
was given to previous published research by the same
principal investigators showing the efﬁcacy of the treat-
ment relative to no treatment or showing superiority
of the treatment compared with other treatment. This
procedure has been proposed as a criterion that gives
information of moderate to strong allegiance.31 We
employed these methods because they allow measure-
ment of all direct (eg, developed the therapy) and
indirect (eg, author published supporting evidence for
the treatment) levels of allegiance in meta-analyses
and primary studies.
Meta-analyses should also fulﬁl the following criteria:
(1) evaluate any form of psychotherapy (eg, psycho-
dynamic, interpersonal psychotherapy, cognitive behav-
ioural therapy (CBT), marital therapy, behavioural
therapy); (2) assess the direct comparison of (a) different
forms of psychotherapy, (b) psychotherapy versus placebo
(treatment as usual, waiting list, no treatment), (c) psycho-
therapy versus medication, (d) group therapy versus
individual or group therapy versus group therapy,
(e) computer-based psychotherapies versus face-to-face
treatments; (3) provide a clear description of the deﬁn-
ition of the main outcome or the class of outcomes regard-
ing both mental and medical disorders. Meta-analyses that
evaluated a combination of psychotherapies and other
alternative treatments (eg, medication) as well as
non-bona ﬁde techniques were also included. Meta-
analyses with studies pertaining to study designs other
than RCTs were excluded.
We excluded meta-analyses which reviewed only the
effects of treatments without having a clear verbal compo-
nent (eg, psychoactive medication, physical exercise) or
those concerning non-speciﬁc treatments without being
compared with a type of psychotherapy (eg, dietary
advice, primary care, recreation). We also excluded narra-
tive reviews and systematic reviews without quantitative
synthesis of data.
To prevent duplicates of the same studies, if an RCT
appeared more than once it was evaluated only in the
context of the ﬁrst publication that described it. We
included primary studies only in the English language
and in full text format. Two investigators (ED and EE)
independently screened both the title and abstract of
identiﬁed articles as well as full text meta-analyses for
eligibility. The decision about the eligibility of a
meta-analysis was made independently by the two
reviewers and disagreements were reached by consensus.
Data extraction
Eligible meta-analyses, including their primary studies,
were reviewed by the ﬁrst investigator (ED) including dis-
closure statements, full texts and tables, author’s afﬁli-
ation, acknowledgments, contributors and references,
and all online journal supplements. During this review
the investigator searched for the presence of RA in each
selected meta-analysis, searched for the presence of RA in
the RCTs included in each meta-analysis and determined
whether or not RA was reported in the meta-analyses and
their RCTs. The investigator also established whether any
statistical procedure of RA was performed in the
meta-analyses and, if so, which method was used according
to the deﬁnition provided by the authors.
For eligible meta-analyses we extracted the following
information: ﬁrst author, year, journal, IF, supplement
issue (Y/N), Cochrane review (Y/N), number of RCTs of
psychotherapy treatments included in the meta-analysis,
number of articles retrieved and reviewed, RA (Y/N),
study population, control/comparison arms, meta-analysis
primary outcome reviewed (eg, efﬁcacy, prevention, both
efﬁcacy and prevention, effectiveness, harm), type of psy-
chotherapy, meta-analysis authors conducted an allegiant
study that was included in the review or advocated the
therapy (Y/N) and their number, total number of meta-
analysis authors, meta-analysis author allegiance reported
(Y/N), meta-analysis author any COI reported (Y/N),
meta-analysis author funding sources reported (Y/N),
meta-analysis reports on allegiance of included RCTs (Y/N),
quality assessment of included RCTs in the meta-analysis (Y/
N), and the allegiance assessment method or meta-analytical
strategy for allegiance of included RCTs in the meta-analysis
(Y/N) (eg, risk of bias, balanced allegiance, subgroup ana-
lysis or meta-regression). We employed the actual deﬁnition
of each meta-analysis in order to categorise the form of psy-
chotherapy treatments (eg, cognitive behavioural therapy,
psychoanalytic/psychodynamic informed psychotherapies,
family systems therapy). We also used the deﬁnition of the
meta-analysis author in terms of meta-analysis outcome (eg,
effectiveness, efﬁcacy).
From the primary included studies we additionally
extracted the following information: ﬁrst author, year,
journal, supplement issue (Y/N), overlapping study
(Y/N), RA in primary RCT (Y/N), number of authors
with allegiance, total number of included authors in
RCTs, RCT authors reported RA (Y/N), RCT authors
provided clear data of their allegiances (Y/N), RCT
authors reported any COI (Y/N), funding sources of
included RCTs reported (Y/N) and, ﬁnally, whether the
RCT authors used any method of controlling for alle-
giance according to the deﬁnition provided by the
authors (eg, balanced allegiance).
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One investigator (ED) extracted all the data and
another investigator (EE) independently conﬁrmed the
extracted data. Disagreements about the above ratings
were discussed until a consensus was reached for each
meta-analysis. If controversial ratings remained, the data
were reassessed by a third party.
Coding of allegiance
Meta-analyses and included RCTs in each eligible
meta-analysis were reviewed in order to identify sufﬁcient
information to code the potential RA, blind to the
results. We used a two-step approach. We ﬁrst rated evi-
dence of various indicators of RA according to a 6-point
scale (from 0 to 5) proposed by Wampold et al,2 as men-
tioned above. We then assigned an absolute allegiance
rating of ‘yes’ (for RA=1–5) and ‘no’ (for RA=0) for each
psychotherapy treatment. This procedure has the advan-
tage of including all possible indicators of allegiance
from strong to weak in both dichotomous and continuous
variables.4 Any ambiguities about coding of allegiance
were solved by discussion until consensus was reached.
Statistical analysis
We report frequencies, medians and IQR. All compari-
sons were performed using the Fisher exact test and
exact test for probabilities. Analysis was performed with
Stata 12.0 (STATA Corp, College Station, Texas, USA)
and two-sided p values are reported.
RESULTS
Search results
The electronic database search yielded 3347 unique arti-
cles of which 146 meta-analyses were eligible (see online
supplementary ﬁgure S1). Of the 146 meta-analyses, 86
were published in 23 scientiﬁc journals (68 specialty psy-
chiatric/psychological journals and 18 general medical
journals) and 60 in CDSR (online supplementary refer-
ences A1–86 and B1–60). The IF of the journals ranged
from 5.8 to 14.46 in specialty journals and from 6.4 to
38.8 in general journals. The IF of the Cochrane
Database was 5.7.
The 146 selected meta-analyses evaluated a broad
spectrum of psychotherapeutic treatments: 25% CBT
alone, 50% mixed various psychotherapy treatments in
addition to CBT, and 25% all other available forms of
psychotherapy alone or in combination. They included
65 studies on treatment effectiveness, 52 on treatment
efﬁcacy, 5 on efﬁcacy and effectiveness, 20 on efﬁcacy
and prevention and adverse events, 1 on harm and 3 on
prevention. Each study included a median of 10 alle-
giant trials (IQR 7–15) and the median number of parti-
cipants per meta-analysis was 1202 (IQR 675–2334).
Detailed characteristics of selected meta-analyses are pre-
sented in online supplementary table S1. The inter-rater
agreement was κ=0.94 in meta-analyses and κ=0.91 in
RCTs.
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Evidence, reporting and assessment of RA in
meta-analyses
Evidence of RA in the meta-analysis was present in 56 of
146 (38.4%) eligible meta-analyses. Moreover, 50 of the
56 (89.3%) had at least one author who was a co-author
in an included RCT that was allegiant in this speciﬁc
study (table 1).
In total, only 25 of the 146 meta-analyses (17.2%) dis-
cussed or reported RA either in the meta-analysis or in
the included RCTs. The level of allegiance was high in 13
meta-analyses and in 12 the level of allegiance was moder-
ate to weak (eg, advocate the treatment). Thirteen of the
146 meta-analyses (8.9%) reported allegiance of the
included RCTs in the text. Ten (6.8%) reported some
kind of evidence of RA by the author(s) of the
meta-analysis in the section on COI, even though all jour-
nals required a declaration of competing interests. Finally,
two meta-analyses (1.4%) reported allegiance in both the
main text and in the section on COI (table 1). The
characteristics of the total meta-analyses with COI state-
ments about allegiances are presented in online supple-
mentary table S2. These percentages differ signiﬁcantly
from the 107 of the 146 selected meta-analyses (73.3%)
that disclosed potential COI other than allegiance (Fisher
exact=92.964, p=1.2×10−29) and the 108 of 146 (74.0%)
that reported the funding sources (Fisher exact=95.124,
p=3.0×10−19). Additionally, only 6 of the 146 meta-ana-
lyses (4.1%) evaluated the presence of allegiance. Details
per journal as well as the total number of meta-analyses
are shown in tables 2 and 3.
Of the 25 meta-analyses that reported allegiance,
9 were published in specialty journals, 2 were published
in general medical journals and 14 were published in
CDSR (p=0.26), while the assessment of RA was per-
formed only in specialty journals and in CDSR.
Speciﬁcally, RA was assessed by different methods
(table 4). Finally, 10 of the 25 meta-analyses that reported
allegiance were published between 2010 and 2012 while
4 of the 6 studies that used a meta-analytic strategy for its
effect were published between 2011 and 2012.
Evidence, reporting and assessment of
RA in included RCTs
The 146 selected meta-analyses synthesised data from
a total of 2727 RCTs. Finally, 1198 RCTs were eligible
for inclusion in the study. Reasons for exclusion are
described in online supplementary ﬁgure S2. The
median number of authors per RCT was 5 (IQR 3–27).
From the 1198 included RCTs, 793 (66.3%) were alle-
giant studies, 142 (11.8%) were non-allegiant and 263
(21.9%) were deﬁned as unclear, taking into account the
absence of clear existence of sufﬁcient information to
code RA. In the 793 allegiant RCTs, evidence of author’s
allegiance through the text was provided in 405 (51.0%)
studies while the remaining 388 (49.0%) provided infor-
mation of allegiance through a cited reference by the
same principal investigators to their previous research.
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The median number of authors with allegiance was 5
(range 3–7 per RCT). With regard to the indicators of
allegiance, in 74 (9.3%) of the 793 included allegiant
studies the treatment was developed and the therapists
were trained or supervised by the allegiant authors (indi-
cator of allegiance=5), while in 458 (57.8%) the treat-
ment was developed by the allegiant authors (indicator
of allegiance=4). In another 85 (10.7%) of the 793
included allegiant studies the treatment was advocated
by one of the authors and they also supervised/trained
the therapists (indicator of allegiance=3), while in 88
(11.1%) of the 793 allegiant studies the treatment was
advocated by the authors but they did not train or super-
vise the therapists and the author showed no advocacy
for the treatment, but provided better trained or more
experienced therapists for one treatment over another
(indicator of allegiance=2). Finally, in 88 (11.1%) of the
793 allegiant studies the treatment was more fully
explained in the introduction and/or methods section
than the alternative (indicator of allegiance=1).
Only 25 of the 793 RCTs (3.2%) clearly stated the term
‘allegiance’ and its derivatives, while only one (0.2%)
reported allegiance as a potential COI in the relevant
section and only one of those (0.2%) assessed the poten-
tial effects of allegiance in their analysis. Sixteen of the 25
primary studies that reported allegiance were studies in
which the allegiant authors ranked with the highest level
of allegiance (eg, developers or developers and trained
or supervised the therapists).The comparison between
strong allegiant RCTs (16/25) and weak allegiant RCTs
(9/25) revealed statistical signiﬁcant differences in terms
of declaration of RA (p=0.003); that is, the stronger alle-
giant RCTs reported allegiance more often than the
weaker allegiant RCTs. In addition, eight of the 25
primary studies that reported allegiance were published
between 2005 and 2009 while the rest were published
before 2005. Furthermore, 118 (14.9%) of the 793 alle-
giant RCTs reported a disclosure statement of their
potential COIs other than allegiance, while funding
sources were reported in 563 (71.2%). The number of
primary studies that disclosed allegiance was signiﬁcantly
different from studies that reported any other COI
(Fisher’ exact=66.476, p=7.2×10−29). On the other hand,
63 of the 405 RCTs that were non-allegiant or of unclear
allegiance (15.5%) reported their potential COIs in a dis-
closure statement while funding sources were reported in
247 of 405 (60.1%) RCTs. Details per journal as well as
the total number of included RCTs are described in
online supplementary tables S3 and S4.
DISCUSSION
To our knowledge, this is the ﬁrst systematic appraisal of
the reporting of allegiance in RCTs and meta-analyses.
We systematically reviewed a large sample size of
meta-analyses of RCTs of psychotherapeutic interven-
tions published in high impact scientiﬁc journals and
their included RCTs. We found that fewer than 20% of
meta-analyses reported allegiance and fewer than 10%
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Table 4 Description of 25 meta-analyses reporting allegiance and 6 meta-analyses reporting estimates of the association between allegiance and outcome
Meta-analysis ID Author Year Journal
Treatment of
interest Age group Clinical population
Section in text where
allegiance of included
RCTs reported
Met analyticalstrategy
for allegiance Statistical method
Positive to
allegiance bias
hypothesis
22466509 Cuijpers et al19 2012 Clin Psychol Rev NDST Adults Depression Abstract, methods and
discussion
Yes Subgroup analysis
(moderator variable)
Yes
21996291 Wampold et al5 2011 Clin Psychol Rev Mixed ESTs Any age Anxiety and depression Introduction, methods,
results, discussion
Yes Studies quality
(moderator variable)
Yes
20547435 Tolin21 2010 Clin Psychol Rev CBT Any age Various mental
disorders
Discussion Yes Meta-regression
(moderator variable)
No
18466666 Smits and
Hofmann
2009 Psychol Med CBT Adults Anxiety disorders Methods and discussion No None None
18055080 Benish et al 2008 Clin Psychol Rev Mixed Adults PTSD Discussion No None None
18049290 Klein et al 2007 J Am Acad Child
Adolesc
Psychiatry
CBT Adolescents Depression Methods, results and
discussion
No None None
16480801 Malouff et al22* 2007 Clin Psychol Rev PST Any age Mental and physical
problems
Results and discussion Yes Meta-regression
(moderator variable)
Yes
17032068 Weisz et al5 2006 Am Psychol Mixed Children and
adolescents
Various youth
problems
Discussion Yes ANOVA (moderator
variable)
No
15583112 Leichsenring et al 2004 Arch Gen
Psychiatry
STTP Adults Specific psychiatric
disorders
Methods and discusion No None No
12237193 Eccleston et al 2002 Pain Mixed Children and
adolescents
Chronic pain Results No None No
10204712 Morley et al 1999 Pain CBT/BT Adults Chronic pain Results No None None
CD005652 Stoffers et al5 2012 CDSR Mixed Adults Borderline personality
disorder
Introduction, methods,
results, discussion, tables,
COI section
Yes Risk of bias Yes
Continued
CD007668
Gibbon et al20 2010 CDSR Mixed Adults Antisocial personality
disorder
Tables, COI section No None None
CD001027 Price et al34 2008 CDSR CBT Adults Chronic fatigue
syndrome
Results No None None
CD004797 Littell et al 2005 CDSR MST Adults Social, emotional, and/
or behavioural
problems
Tables No None None
CD009514 Smith et al18 2011 CDSR Relaxation
techniques
Adults (only
women)
Pain management COI section No None None
CD004025 Mössler et al13 2011 CDSR Music therapy Any age Schizophrenia COI section No None None
CD002902 Whalley et al17 2011 CDSR Mixed Adults Coronary heart disease COI section No None None
CD002014 Henschke et al19 2010 CDSR CBT/BT Adults Chronic low back pain COI section No None None
CD007944 Roberts et al37 2010 CDSR Mixed Any age Acute traumatic stress
symptoms
COI section No None None
CD005378 Ruddy and
Dent-Brown
2007 CDSR Drama
therapy
Adults Schizophrenia COI section No None None
CD004687 Abbass et al 2006 CDSR STPP Adults Common mental
disorders
COI section No None None
CD004717 Crawford-Walker
et al
2005 CDSR Distraction
techniques
Any age Schizophrenia COI section No None None
CD001134 Dennis and
Creedy
2004 CDSR Mixed Adults (only
women)
Postpartum depression COI section No None None
CD000524 Jones et al 2004 CDSR CBT Any age Schizophrenia COI section No None None
*Whether a developer of PST conducted the study under investigation (no term allegiance).
BT, behavioural therapy; CBT, cognitive behavioural therapy; CDSR, Cochrane Database of Systematic Reviews; COI, conflict of interest; EST, empirically supported therapy;
MST, multisystemic therapy; NDST, non-directive supportive therapy; PST, problem-solving therapy; PTSD, post traumatic stress disorder; RCT, randomised controlled trial;
STTP, short-term psychodynamic psychotherapy.
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included a statement about the allegiant author(s) in
the meta-analyses in the text or as a disclosure statement
elsewhere. Although allegiance was present in two-thirds
of the eligible included RCTs, fewer than 5% reported
allegiance in the text or as a disclosure statement.
The results of the present study highlight a major gap,
given that there is agreement in the literature on the
necessity of a more targeted approach on the allegiance
effect among researchers and readers.1–13 17–31
According to Staines and Cleland,29 “RA represents a
major overestimation bias, is a frequent phenomenon
applied directly to both primary studies and
meta-analyses and additionally meta-analysts, like primary
investigators, can exhibit allegiance to a hypothesis being
tested”. Poor reporting in meta-analyses and RCTs is
crucial because both designs are considered to be the
gold standard in evidence-based practice.34 This could
imply that many researchers ignore—or, at best, are
unaware of—the effect of this phenomenon regardless of
the way it inﬂuences the results of the studies.1–13 17–31 35
Even in psychotherapy research where allegiance
effects have been discussed and conceptualised very
early,7 11–13 14–18 24 25 28 there is a lack of sensitivity for
such potential biases. We found that RA was coded and
analysed in a trivial number of meta-analyses. Two plaus-
ible explanations can be provided. First, the state of RA
is still debatable in terms of possible bias and, although
it may be universal in practice settings, its nature effects
vary considerably in the literature.2 5 6 23–25 31 It is a fact
that RA stretches back to the famous Dodo verdict11 and
also challenges in terms of a better performance in
delivery of treatment.1 3 24 25 Very often RA is used as a
moderator variable to look at differences between
studies.2 5 6 19–23 27 Second, information on allegiance is
not typically reported by the term ‘allegiance’ in original
reports. Moreover, the deﬁnition of allegiance differs
from study to study. Even if some authors of
meta-analyses are familiar with this factor and are willing
to investigate RA effects, they have to rely on non-
standardised measuring methods3 like reprint analysis
(ie, analysis of the publication for the presence of attri-
butes that may hint at allegiance) based on the limited
information available in thepublished articles.1 2 4 17 21 31 36
However, it is important to point out that reprint analysis
as well as other such procedures including interviews
with colleagues of the researchers of interest and inter-
views with the researchers themselves27 or examinations
of previous publications authored by the same work
groups31 are generally problematic and therefore might
lead to erroneous conclusions.3
This study suggests that, without a strict reporting
policy, RA is unlikely to be reported in meta-analyses and
RCTs. Psychotherapy should move forward, following
what is accomplished with pharmaceutical industry trials
and sponsorship biases.15 32 33 37 Similar statements to
the PRISMA statement could be adopted or extended to
require authors of meta-analyses to report RA of both
meta-analyses and primary studies or report that RA was
not disclosed. Meta-analysis authors should report that
they have evaluated all potentially relevant sources of
bias. Developers of treatments might be encouraged to
collaborate with other independent researchers when
conducting meta-analyses of their own treatments and
any potential personal or ﬁnancial gain should be dis-
closed. It is also possible that some researchers may have
a ﬁnancial interest in the treatment—that is, they were
involved in training and workshops related to the treat-
ment. However, even if the authors do not have such
involvement, they might still beneﬁt from characterisa-
tion of their preferred treatment as evidence-based.
Other approaches in meta-analyses such as balanced alle-
giance, subgroup analysis or reporting results by levels of
allegiance29 could be adopted as a sensitivity analysis.
The investigators of RCTs should have to report their
methods (eg, outcome of interest or data analytical
methods) before implementation of a clinical trial.
Furthermore, the researchers should control for RA by
balancing it, at least, when two different psychothera-
peutic treatments are compared in a clinical trial. They
should also employ another set of researchers to make
interpretations of the ﬁndings and perhaps, by this
method of selecting blind assessors, the RA effects could
be minimised. It is important for the psychotherapy ﬁeld
to offer the best reliable guide to policy makers, clinicians
and readers, endeavouring to evaluate the relative costs
and beneﬁts of choosing a particular therapy over others.
There are some caveats in our study. Our investigation
is limited to high impact journals only and therefore we
may have not captured meta-analyses and RCTs from
other clinically impactful journals on psychotherapy
research. However, our collection of journals includes a
wide range of journals including several specialised in
psychotherapy research such as Clinical Psychology Review,
Psychotherapy and Psychosomatics, Psychological Bulletin and
Psychological Medicine. Also, this rule applies only to the
eligible meta-analyses and not to their included RCTs,
ensuring an unbiased sample. Our approach assessed
only RCTs included in the eligible meta-analyses and
therefore other RCTs in the literature have not been
appraised. Nevertheless, there is no evidence that this
additional information would be signiﬁcantly different
from our collection of RCTs, and the large number of
included studies gives us statistical power to derive solid
inferences. A formal comparison of reporting in
meta-analyses and RCTs would be of interest. However,
the RCTs included here have been published in journals
with signiﬁcantly lower IFs and any possible differences
could reﬂect differences in the reporting practices
between high impact and lower impact journals, and not
the actual difference between the two designs. Another
limitation is the coding of allegiance, since to date there
is no unique accepted assessment of RA. However, we
tried to measure all possible direct and indirect indica-
tors of allegiance. Other studies in the ﬁeld have used
similar approaches.2 17 31 36 Moreover, it has been found
that the type of measurement did not alter the strong
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association between allegiance and treatment effect.23
Finally, although we found that the majority of allegiant
authors of the primary studies had strong allegiance
with the preferred treatment (eg, developed it or devel-
oped it and supervised/trained the therapist), we have
not explored the role of funding sources as an indicator
of the existence of allegiance. However, positive effects
of treatments were reported by studies without the
involvement of the developers or sponsorships.38 Hence,
we have only compared the current reporting of alle-
giance versus the reporting of any other potential
factors that inﬂuence a researcher’s actions and the
reporting of results in the conducted studies, such as
COIs and funding sources.
In conclusion, we found that the vast majority of
meta-analyses and primary RCTs of psychotherapeutic
treatments published in high-impact journals failed to
report RA. Since allegiance exists in psychotherapy
research as an inﬂuential factor or bias, revised guide-
lines might be required for the standardised reporting
of this information in a more systematic manner.
Indeed, the Cochrane handbook mentions that authors
may consider that any potential bias related to the inﬂu-
ence of possible bias or potential COIs could be evalu-
ated as an optional ‘other sources of bias’ domain using
the risk of bias tool.39 Therefore, coding as well as ana-
lysing the effect of RA in every meta-analysis may be the
ﬁrst step in order to clarify the extent of the role of alle-
giance on psychotherapy outcome research. We believe
that a distinct statement of the role of each author’s con-
tribution regarding the psychotherapy treatment under
investigation similar to the COI statement could be a
proper method of standardising the measurement of
RA. Potential sources of allegiance should be thoroughly
considered, and potential allegiance effects should be
extensively discussed by an expert panel in order to
consent on speciﬁc recommendations on reporting, as
in other ﬁelds. Optimal clear reporting of any level of
RA in RCTs and meta-analyses would improve the trans-
parency of the studies and facilitate the replication of
the results.
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